Pfizer Documents Reveal Heart Problems After mRNA Vaccination What the Evidence Really Shows

0 followers
Share
Save
Report
  • Save
  • Report
7 views  
17 hours ago
Did Pfizer’s own documents acknowledge heart problems following its mRNA COVID-19 vaccine? Official regulatory records show that myocarditis and pericarditis became recognized safety risks associated with mRNA COVID-19 vaccination, particularly among younger males. The FDA says these risks were added to the vaccine labeling in 2021 and that subsequent surveillance continued to identify cases. But what did Pfizer and regulators know at different stages of the vaccine rollout? Were early warning signals visible in the clinical data, or did the clearest evidence emerge only after millions of doses had been administered? And what do later studies reveal about people who developed vaccine-associated myocarditis? This investigation examines the Pfizer documents, clinical-trial data, post-market surveillance and later regulatory updates. What was known, when was it known, and does the evidence support the claim that Pfizer “admitted” to heart problems?

Share Video

Add to

Flag Video

Rate video

Rate video

Follow

Subscribe

Up next
Autoplay